Sinisa Markovic

Showing 1-4 of 4 articles

Interventions for valvular disease

First experience with the MitraClip XTR device for extensive mitral valve prolapse (Barlow’s disease)

Weinmann K, Markovic S, Rottbauer W, Keßler M

December 20, 2018 | 10.4244/EIJ-D-18-00556

Coronary interventions

Bioresorbable polymer sirolimus-eluting coronary stent compared with permanent polymer everolimus-eluting coronary stent implantation for treatment of small vessel coronary artery disease: CENTURY II trial

Wöhrle J, Markovic S, Rottbauer W, Muramatsu T, Kadota K, Vázquez-González N, Odenstedt J, Serra A, Antoniucci D, Varenne O, Saito S, Wijns W

June 10, 2016 | 10.4244/EIJV12I2A30

Beyond the early stages: insights from the ASSURE registry on bioresorbable vascular scaffolds

Wöhrle J, Naber C, Schmitz T, Schwenke C, Frey N, Butter C, Brachmann J, Ingwersen M, Drabik A, Markovic S, Mathey D

June 19, 2015 | 10.4244/EIJY14M12_10

Efficacy of different devices for transcatheter closure of patent foramen ovale assessed by serial transoesophageal echocardiography and rates of recurrent cerebrovascular events in a long-term follow-up

Luani B, Markovic S, Krumsdorf U, Rottbauer W, Wöhrle J

May 19, 2015 | 10.4244/EIJY15M01_02

1

Latest news

LM revascularisation, annulus rupture, risk stratification, renal denervation

Ahead of print: Transcatheter treatment of multivalvular heart disease

Cardioband after placement of 17 screws before and after

Balancing risks and benefits of LM revascularisation strategies in CKD patients

Gennaro Giustino

Last Update: CULPRIT, NOBEL, IVUS-XPL, SAFARI-STEMI

(supported by Biotronik)

Guidance Papers

Guidelines, consensus & position papers

Contained annulus ruptures – the price to pay for optimal haemodynamic results?

Fabian Nietlispach

This week’s JAA’s: Paradigm Study: 12months outcome, GLASSY ACS vs SIHD...

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke